Herbal Medicine Intervention for the Treatment of COVID-19: A Living Systematic Review and Cumulative Meta-Analysis

Lin Ang1, Eunhye Song2, Xiao-Yang Hu3

  • 1KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, South Korea.

Insights

Integrative herbal medicine shows potential benefits for treating coronavirus disease 2019 (COVID-19) symptoms when used alongside standard care. However, the evidence quality is low, and more research is needed to confirm these findings.

Area of Science:

  • Integrative Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Integrative herbal medicine is increasingly explored for its potential therapeutic effects in managing symptoms associated with coronavirus disease 2019 (COVID-19).
  • A comprehensive review of existing evidence is crucial to understand the benefits and risks of using herbal medicine as an adjunct therapy for COVID-19.

Approach:

  • A systematic literature search was conducted across eleven major databases, including PubMed, CENTRAL, Embase, AMED, and several Chinese and Korean databases, from June 2020 to March 2022.
  • Randomized controlled trials (RCTs) evaluating the efficacy and safety of herbal medicine in patients with PCR-confirmed COVID-19 were included, irrespective of language or patient age.
  • Data extraction and quality assessments were performed independently by researchers to ensure methodological rigor.

Key Points:

  • Meta-analyses indicated that herbal medicine, when added to standard treatment, significantly improved total effective rates, reduced time to fever and cough remission, and decreased fatigue and sputum production.
  • Adjunctive herbal medicine also showed benefits in improving chest CT scan manifestations, reducing progression to severe COVID-19, lowering all-cause mortality, and shortening hospital stays and time to negative COVID-19 tests.
  • No significant differences were observed in the remission rates of specific symptoms like sore throat or nasal congestion, nor in the incidence of adverse events between groups. The risk of bias in included RCTs was generally unclear.

Conclusions:

  • Current evidence suggests that incorporating herbal medicine into standard treatment protocols may offer potential benefits for managing COVID-19 symptoms.
  • Despite promising results, the overall certainty of the evidence is low, highlighting the need for high-quality research to validate these findings and assess long-term safety.